EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONE

被引：0
|
作者：
Han, Chenglong [1 ]
Gathany, Tim [1 ]
Tandon, Neeta [2 ]
Hsia, Elizabeth [3 ]
机构：
[1] Janssen Global Serv LLC, Worldwide Market Access, Malvern, PA USA
[2] Janssen Sci Affairs LLC, Hlth Econ & Outcomes Res, Horsham, PA USA
[3] Janssen Res & Dev Inc, Immunol, Malvern, PA USA
来源：
RHEUMATOLOGY | 2012年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：172 / 172
页数：1
相关论文
共 50 条
  • [1] EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONE
    Han, C.
    Gathany, T.
    Tandon, N.
    Hsia, E.
    VALUE IN HEALTH, 2011, 14 (03) : A131 - A132
  • [2] Employability-Adjusted-Life-Years in Patients with Rheumatoid Arthritis Treated with Golimumab Plus Methotrexate or Methotrexate Alone.
    Han, Chen-glong
    Gathany, Tim
    Tandon, Neeta
    Hsia, Elizabeth C.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S52 - S52
  • [3] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [4] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [5] Comparison of employable life-years in patients with rheumatoid arthritis treated with infliximab plus methotrexate or methotrexate alone: A preliminary analysis using a Markov model
    Han, C.
    Tang, B.
    Parasuraman, S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S472 - S472
  • [6] Efficacy of golimumab plus methotrexate in methotrexate-na⟨ve patients with severe active rheumatoid arthritis
    Emery, Paul
    Fleischmann, Roy M.
    Hsia, Elizabeth C.
    Xu, Stephen
    Zhou, Yiying
    Baker, Daniel
    CLINICAL RHEUMATOLOGY, 2014, 33 (09) : 1239 - 1246
  • [7] Efficacy of golimumab plus methotrexate in methotrexate-naïve patients with severe active rheumatoid arthritis
    Paul Emery
    Roy M. Fleischmann
    Elizabeth C. Hsia
    Stephen Xu
    Yiying Zhou
    Daniel Baker
    Clinical Rheumatology, 2014, 33 : 1239 - 1246
  • [8] Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-α blocker plus methotrexate versus methotrexate or leflunomide alone
    Margaret Wisłowska
    Danuta Jakubicz
    Rheumatology International, 2007, 27 : 641 - 647
  • [9] A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate
    Chuanpu Hu
    Zhenhua Xu
    Mahboob U. Rahman
    Hugh M. Davis
    Honghui Zhou
    Journal of Pharmacokinetics and Pharmacodynamics, 2010, 37 : 309 - 321
  • [10] A latent variable approach for modeling categorical endpoints among patients with rheumatoid arthritis treated with golimumab plus methotrexate
    Hu, Chuanpu
    Xu, Zhenhua
    Rahman, Mahboob U.
    Davis, Hugh M.
    Zhou, Honghui
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2010, 37 (04) : 309 - 321
12345